View All Documents & Correspondence
Method For Producing A Liposome Composition Comprising Gemcitabine
Abstract: The present invention discloses a method for producing a liposome composition in which gemcitabine or a salt thereof is contained in a liposome, which comprises; mixing an oil phase in which at least one kind of lipid is dissolved in an organic solvent with an aqueous phase, stirring the resultant aqueous solution containing the lipid, and evaporating the organic solvent from an aqueous solution containing the liposomes obtained in the stirring step, wherein the organic solvent is a mixed solvent of a water-soluble organic solvent and an ester-based organic solvent, and wherein the liposome composition is used as a tumor therapeutic agent
Notices, Deadlines & Correspondence
Patent Information
Applicants
FUJIFILM Corporation
Inventors
1. KITAHASHI, Tsukasa
2. MIMA, Shinji
3. MATSUMOTO, Takeshi
4. SEKIGUCHI, Takahiro
5. MORI, Mikinaga
Specification
Claims:Please see the attachment , Description:Please see the attachment
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 202048043283-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [05-10-2020(online)].pdf | 2020-10-05 |
| 2 | 202048043283-STATEMENT OF UNDERTAKING (FORM 3) [05-10-2020(online)].pdf | 2020-10-05 |
| 3 | 202048043283-REQUEST FOR EXAMINATION (FORM-18) [05-10-2020(online)].pdf | 2020-10-05 |
| 4 | 202048043283-PROOF OF RIGHT [05-10-2020(online)].pdf | 2020-10-05 |
| 5 | 202048043283-FORM 18 [05-10-2020(online)].pdf | 2020-10-05 |
| 6 | 202048043283-FORM 1 [05-10-2020(online)].pdf | 2020-10-05 |
| 7 | 202048043283-FIGURE OF ABSTRACT [05-10-2020(online)].pdf | 2020-10-05 |
| 8 | 202048043283-DRAWINGS [05-10-2020(online)].pdf | 2020-10-05 |
| 9 | 202048043283-DECLARATION OF INVENTORSHIP (FORM 5) [05-10-2020(online)].pdf | 2020-10-05 |
| 10 | 202048043283-COMPLETE SPECIFICATION [05-10-2020(online)].pdf | 2020-10-05 |
| 11 | 202048043283-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [05-10-2020(online)].pdf | 2020-10-05 |
| 12 | 202048043283-FORM-26 [09-10-2020(online)].pdf | 2020-10-09 |
| 13 | 202048043283-FORM 3 [08-12-2020(online)].pdf | 2020-12-08 |
| 14 | 202048043283-FORM 3 [26-04-2021(online)].pdf | 2021-04-26 |
| 15 | 202048043283-OTHERS [09-08-2021(online)].pdf | 2021-08-09 |
| 16 | 202048043283-FORM 3 [09-08-2021(online)].pdf | 2021-08-09 |
| 17 | 202048043283-FER_SER_REPLY [09-08-2021(online)].pdf | 2021-08-09 |
| 18 | 202048043283-CLAIMS [09-08-2021(online)].pdf | 2021-08-09 |
| 19 | 202048043283-Annexure [09-08-2021(online)].pdf | 2021-08-09 |
| 20 | 202048043283-FER.pdf | 2021-10-18 |
| 21 | 202048043283-US(14)-HearingNotice-(HearingDate-10-03-2022).pdf | 2022-02-10 |
| 22 | 202048043283-Correspondence to notify the Controller [07-03-2022(online)].pdf | 2022-03-07 |
| 23 | 202048043283-Written submissions and relevant documents [25-03-2022(online)].pdf | 2022-03-25 |
| 24 | 202048043283-Retyped Pages under Rule 14(1) [25-03-2022(online)].pdf | 2022-03-25 |
| 25 | 202048043283-2. Marked Copy under Rule 14(2) [25-03-2022(online)].pdf | 2022-03-25 |
Search Strategy
| 1 | 201847016588SSE_08-02-2021.pdf |